Sanofi Pasteur is pleased to announce that the new 3-in-1 ADACEL® Booster vaccine is now available in South Africa from DSV and all major wholesalers
ADACEL® is indicated for active booster immunisation for the prevention of tetanus, diphtheria and pertussis (whooping cough) in persons 4 years of age and older, according to local immunisation recommendations. Passive protection against pertussis in early infancy following maternal immunization during pregnancy. Persons who have had pertussis, tetanus or diphtheria, should still be immunized since these clinical infections do not always confer immunity.
|Product name||Adacel® vial 0.5 ml VAC||EAN barcode||6009637910113|
|Nappi code||3002510001||DSV code||622052|
|Schedule||S2||Presentation||1 pack contains: 1 x 2.0 ml single dose glass vial|
|SEP excl. VAT||R261.77||SEP incl. VAT||R301.04|
Sanofi Pasteur is constantly striving to meet customer needs. We are therefore pleased to announce the launch of Adacel®.
1 Adacel® package insert (11/2020)
S2 ADACEL® Suspension for injection. Each 0.5 ml dose contains: Tetanus toxoid 5 Lf; Diphtheria toxoid 2LF; Pertussis toxoid 2.5 µg; Filamentous haemagglutinin 5 µg; Pertactin 3 µg; Fimbriae types 2 and 3.5 µg. Reg. No.:51/30.1/0837. For full prescribing information please refer to the package insert.
MAT-ZA-2001144 – 1.0 – 11/2020